Human Leukocyte Antigen-DR and Cluster Designation 34: Double-negative Acute Myeloid Leukemias – Our Experience in Clinical Setting
Introduction: Dual negativity for cluster designation (CD) 34 and human leukocyte antigen (HLA)-DR antigen in leukemia panel is an important finding in clinical practice. The combination of this finding though seen classically in acute promyelocytic leukemia (APL) is not specific to it but can be se...
Saved in:
| Main Authors: | Preeti Tripathi, Sanjeev Khera, Rajiv Kumar, Rajan Kapoor, Umesh Kapoor, Naveen Chawlar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Journal of Marine Medical Society |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jmms.jmms_65_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-03-01) -
Aphallia in a patient with 9q34 duplication syndrome: a case report
by: Juan Pablo Meza-Espinoza, et al.
Published: (2025-05-01) -
Correlation between neutrophils-to-lymphocyte ratio and soluble FMS-like tyrosine kinase 1 in pregnant women with preeclampsia
by: Kiki Rizki Amelia, et al.
Published: (2025-04-01) -
Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression
by: Davut Pehlivan, et al.
Published: (2024-12-01) -
Decoding the impact of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist on cardiometabolic health: inflammatory mediators at the focus
by: Fang Cheng, et al.
Published: (2025-05-01)